Abstract
Rationale: The contributions of diverse cell populations in the human lung to pulmonary fibrosis pathogenesis are poorly understood. Single-cell RNA sequencing can reveal changes within individual cell populations during pulmonary fibrosis that are important for disease pathogenesis. Objectives: To determine whether single-cell RNA sequencing can reveal disease-related heterogeneity within alveolar macrophages, epithelial cells, or other cell types in lung tissue from subjects with pulmonary fibrosis compared with control subjects. Methods: We performed single-cell RNA sequencing on lung tissue obtained from eight transplant donors and eight recipients with pulmonary fibrosis and on one bronchoscopic cryobiospy sample from a patient with idiopathic pulmonary fibrosis. We validated these data using in situ RNA hybridization, immunohistochemistry, and bulk RNA-sequencing on flow-sorted cells from 22 additional subjects. Measurements and Main Results: We identified a distinct, nove population of profibrotic alveolar macrophages exclusively in patients with fibrosis. Within epithelial cells, the expression of genes involved in Wnt secretion and response was restricted to nonoverlapping cells. We identified rare cell populations including airway stem cells and senescent cells emerging during pulmonary fibrosis. We developed a web-based tool to explore these data. Conclusions: We generated a single-cell atlas of pulmonary fibrosis. Using this atlas, we demonstrated heterogeneity within alveolar macrophages and epithelial cells from subjects with pulmonary fibrosis. These results support the feasibility of discovery-based approaches using next-generation sequencing technologies to identify signaling pathways for targeting in the development of personalized therapies for patients with pulmonary fibrosis.
Original language | English (US) |
---|---|
Pages (from-to) | 1517-1536 |
Number of pages | 20 |
Journal | American journal of respiratory and critical care medicine |
Volume | 199 |
Issue number | 12 |
DOIs | |
State | Published - Jun 15 2019 |
Funding
P.A.R. is supported by Northwestern University’s Lung Sciences Training Program 5T32HL076139-13 and 1F32HL136111-01A1. J.M.W. is supported by Northwestern University’s Lung Sciences Training Program 5T32HL076139-14 and Dixon Translational Research Grant. D.R.W. is supported by the Northwestern Memorial Foundation Dixon Award, the Arthritis National Research Foundation, the American Lung Association, the Scleroderma Foundation, and ATS Foundation/Mallinckrodt Pharmaceuticals Inc. Research Fellowship. S.H. is supported by Northwestern University’s Lung Sciences Training Program 5T32HL076139. C.A.B. is funded by HL119995. R.B.H. is supported by AR066579 and ATS Foundation Unrestricted Grant. R.D.G. is supported by HL125910. G.M.M. is supported by NIH grants ES015024, ES025644, and ES0236718. A.B. is supported by NIH grant HL125940 and matching funds from Thoracic Surgery Foundation, research grant from Society of University Surgeons, and John H. Gibbon Jr. Research Scholarship from American Association of Thoracic Surgery. M.J. is supported by The Veterans Administration grant BX000201. B.D.S. is supported by HL128867 and the Parker B. Francis Research Opportunity Award. J.I.S. is supported by NIH grants AG049665, HL048129, HL071643, and HL085534. K.M.R. is supported by NIH grants HL128194, HL071643, and AG049665. H.P. is supported by NIH grants AR064546, HL134375, AG049665, and UH2AR067687 and the United States-Israel Binational Science Foundation (2013247), the Rheumatology Research Foundation (Agmt 05/06/14), Mabel Greene Myers Professor of Medicine, and generous donations to the Rheumatology Precision Medicine Fund. C.J.G. and A.P.L. are supported by NIH grant HL143800. A.P.L. is supported by NIH HL127245, Scleroderma Foundation, and Respiratory Health Association grants. G.R.S.B. is supported by NIH grants ES013995, HL071643, AG049665, the Veterans Administration Grant BX000201, and Department of Defense grant PR141319. A.V.M. is supported by NIH grants HL135124 and AI135964 and Department of Defense grant PR141319. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program under Award W81XWH-15-1-0215 (G.R.S.B. and A.V.M.). Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. Flow cytometry cell sorting was performed on a BD FACSAria SORP system, purchased through the support of NIH 1S10OD011996-01. Multiphoton microscopy was performed on a Nikon A1R multiphoton microscope, acquired through the support of NIH 1S10OD010398-01. sequencing on the Illumina HiSeq 4000 was performed by the NUSeq Core Facility, which is supported by the Northwestern University Center for Genetic Medicine, Feinberg School of Medicine, and Shared and Core Facilities of the University’s Office for Research. Northwestern University Flow Cytometry Facility, Center for Advanced Microscopy, and Pathology Core Facility are supported by NCI Cancer Center Support Grant P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. This research was supported in part through the computational resources and staff contributions provided by the Genomics Computing Cluster (Genomic Nodes on Quest), which is jointly supported by the Feinberg School of Medicine, the Center for Genetic Medicine, and Feinberg’s Department of Biochemistry and Molecular Genetics, the Office of the Provost, the Office for Research, and Northwestern Information Technology. The Genomics Computing Cluster is part of Quest, Northwestern University’s high-performance computing facility, with the purpose to advance research in genomics. This publication is part of the Human Cell Atlas (www.humancellatlas.org/ publications).
Keywords
- Alveolar macrophages
- Alveolar type II cells
- Pulmonary fibrosis
- RNA sequencing
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine